The market performance of Unicycive Therapeutics Inc has been somewhat stable. Over the past year, the company’s stock achieved a high of $1.82 on 02/22/24, with the lowest value for the same timeframe being $0.20, recorded on 08/13/24.
52-week price history of UNCY Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Unicycive Therapeutics Inc’s current trading price is -56.56% away from its 52-week high, while its distance from the 52-week low is 290.99%. The stock’s price range during this period has fluctuated between $0.20 and $1.82. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.87 million for the day, which was evidently higher than the average daily volume of 1.52 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Unicycive Therapeutics Inc (UNCY) has experienced a quarterly rise of 92.59% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 81.97M and boasts a workforce of 14 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.4747, with a change in price of +0.3919. Similarly, Unicycive Therapeutics Inc recorded 2,034,970 in trading volume during the last 100 days, posting a change of +98.49%.
UNCY Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for UNCY stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.01.
UNCY Stock Stochastic Average
The raw stochastic average for Unicycive Therapeutics Inc over the last 50 days is presently at 84.05%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 70.94%. Further, the company’s Stochastic %K and %D values for the last 20 days were 49.68% and 43.64%, respectively.
UNCY Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -8.98% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 94.96%. Over the past 30 days, the price of UNCY has fallen by 42.92%. And in the last five days, it has surged by 20.03%.
